Back to search

Article

Identifying therapeutic targets for rheumatoid arthritis by genomics-driven integrative approaches

2024-03-20

Abstract excerpt

<h4>Summary</h4> Genomics-driven drug discovery framework holds promise in developing novel therapeutic targets. Here, we leveraged large-scale genomic data including genome-wide association studies (GWAS), rare variant burden tests in exome sequencing studies (Exome), and protein quantitative trait loci (pQTL), to prioritize potential therapeutic targets and identify opportunities for drug repositioning in rheuma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4aa10a53-f852-5a06-83a9-8aae0adad062
DOI
10.1101/2024.03.19.24304536
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identifying therapeutic targets for rheumatoid arthritis by genomics-driven integrative approachesDOI 10.1101/2024.03.19.24304536
Select a neighboring publication to make it the new centre.